Our Sectors
We are experts at what we do
01
Our People
A dedicated team of executive search experts, delivering for you
The Compass Carter Osborne team are healthcare and life science experts. As a trusted advisor we bring decades of search experience and an unparalleled track record of delivery across our dedicated sectors for our investor clients – relied upon time and again to build outstanding leadership teams.
Familiar faces at key industry events, our expertise extends beyond the mere placing of people with our consultants bringing together sector leaders to address key challenges, working in partnership to produce tangible solutions.
02
Expertise
Unearthing rare talent, that drive successful exits
Responsive, adaptable, and emotionally intelligent, Compass Carter Osborne avoid the one-size-fits-all approach to ensure our clients achieve their desired outcome by presenting a broad range of intuitive, tailored solutions, based on specific needs.
03
Our Approach
Tailoring our offering,
to provide a bespoke service
Results driven, not process led, CCO avoid the conformity of a rigid process. Never assumptive, we listen and adopt an agreed approach which most closely delivers to a clients specific needs. Understanding the uniqueness of each role, our people tailor a search to bespoke requirements to ensure solutions that delivers the best possible results first time, every time.
A trusted advisor to the investment community
providing leaders advancing the healthcare and life sciences sectors
What our clients say
“Compass Carter Osborne really delivered for us in our search for a new CEO for Outcomes First Group. It was a vitally important assignment given that we were recruiting a successor for a long standing and highly successful CEO in a sector-leading business. Compass Carter Osborne went above and beyond in developing a deep understanding of the business and our requirements, and in only presenting candidates that closely met these. They think very creatively and their focus was very sharp; they particularly understood the culture of the business. The search was speedy and well organised, with a very high standard of verbal and written feedback. They have a granular knowledge of the sector and because of the way in which they work, we were fully involved throughout and achieved a great result. A really excellent search – thank you.”
Outcomes First Group – Chair
“Compass Carter Osborne started from the very beginning with a detailed, professional explanation of the available position. They spent time to present the great opportunity and chance to accelerate my career but at the same time, the challenge, and the strong expectation from their client.”
Hengrui Therapeutics – VP, Head Biological Drug Discovery
“Compass Carter Osborne delivered on a key appointment for the PFA and the wider football industry. It was a complex brief involving creating an entirely new position. The role was vitally important, with the successful candidate taking on a sensitive and multifaceted responsibility across CTE, concussion and brain health in professional football. CCO led a comprehensive and exhaustive process, developing a deep understanding of the union’s requirements and using his expert knowledge to help scope and evolve the brief throughout the search. The entire process was professional, efficient and well organised, with consistent communication and feedback at every stage.”
The Professional Footballers Association (PFA) – Chief Executive Officer
“I have been so impressed by Luke’s integrity, clear purpose and drive to achieve for his clients. Luke has worked with Priory on a number of things but more recently to source two independent Non Executive Directors and a Director of Talent Acquisition. He has kept us informed, fielded some great candidates and follows up at each stage, even when they have started. I would really recommend him if you are searching for high calibre individuals.”
Priory Group – Chief Executive Officer
“I recently had the pleasure of being appointed to an independent healthcare provider as a NED after being put forward for the role by Luke. Throughout the whole recruitment process I was treated with respect and felt valued. I was particularly impressed with the follow up support after the decision to appoint me, which I have never experienced from other search companies. Luke continued to check in with me to ensure my onboarding went smoothly and that I had settled into the role. Overall, a highly professional and comprehensive approach delivered personally by Luke.”
Priory – Independent Non-Executive Director
“Luke was absolutely brilliant along the journey. He acted as a real partner and was able to answer to all my questions in order to get comfortable with the decision of making the change. His expertise and knowledge of the sector really came out along the process. Most importantly, he was always available when I needed him to be, which is something I valued a lot. In summary, I couldn’t recommend him and Compass Carter Osborne enough.”
AniCura – Group Chief Operating Officer
“We worked with Compass Carter Osborne in the search for our Chief Financial Officer and from the start it was clear they were a good choice of partner. A focus on understanding our needs as a business, and mine personally as a CEO were front of mind for Paul and Kieran. They took the time to listen, understand and not only focus on the functional aspects of the role – but critically, the team fit and culture we are building.
Process, structure and follow-through were like clockwork, and the quality of candidates were of a consistently high-level. I would highly recommend Compass Carter Osborne.”
Renaiss Health – Chief Executive Officer
“I’ve known Tarquin for over 15 years, during which time he has delivered a number of executive assignments at senior level, including COO/executive team and senior management roles in scientific/professional disciplines (his network in the biotech/life-sciences sector is second-to-none!). He works hard to truly understand both the candidate brief and the culture of the company, sets realistic expectations and retains regular contact as an assignment progresses, always providing thorough updates and pragmatic advice. He has the highest levels of professionalism and integrity – he really is a pleasure to work with.”
One Nucleus – Director
“Jamie did a great job – he really took the time to understand our business, our needs and what we were looking for. We knew our brief was specific, yet Jamie met all our expectations with the search. He maintained a high standard of communication and meticulous attention to detail throughout the process. I would recommend Jamie and the Compass Carter Osborne team without hesitation.”
Melrose Education – Chair & CEO
“Our recent work with Compass Carter Osborne was exceptional. The search was perfectly organised, response times were swift, and due to the consultant market knowledge and network, we quickly found our ideal candidate.”
Schoen Clinic – Member of Group Executive
Healthcare news, data and analysis
Via Investors in Healthcare
Switzerland: Galderma rated BBB by S&P with positive outlook
Six-listed Galderma, a global pure-play manufacturer of dermatology products, has received a BBB long-term issuer credit rating with a positive outlook from S&P. The rating reflects Galderma’s strong track record […]
Six-listed Galderma, a global pure-play manufacturer of dermatology products, has received a BBB long-term issuer credit rating with a positive outlook from S&P. The rating reflects Galderma’s strong track record […]
Switzerland: Galderma rated BBB by S&P with positive outlook
December 5, 2025
Cosmetic & Aesthetics
Debt
Healthcare
News
Galderma
France: Asker makes first add-on in France with acquisition of Cardio Dépôt
Asker Healthcare Group, a Stockholm-listed provider of medical products and solutions to the European healthcare sector, has acquired Cardio Dépôt, a niche distributor of medical devices and consumables within cardiology […]
Asker Healthcare Group, a Stockholm-listed provider of medical products and solutions to the European healthcare sector, has acquired Cardio Dépôt, a niche distributor of medical devices and consumables within cardiology […]
France: Asker makes first add-on in France with acquisition of Cardio Dépôt
December 5, 2025
Digital Health/Healthtech
Healthcare
Life Sciences
M&A
Medtech – Healthcare IT
UK: PSC announces new investment and strategic partnership
Person Centred Software (PCS), a UK care management software provider, has announced a partnership with Clearcare, a UK provider of children’s social care software, a new investment from Brighton Park […]
Person Centred Software (PCS), a UK care management software provider, has announced a partnership with Clearcare, a UK provider of children’s social care software, a new investment from Brighton Park […]
UK: PSC announces new investment and strategic partnership
December 5, 2025
Children’s Residential Services
Digital Health/Healthtech
Education
Healthcare
M&A
UK: NHS pharmaceuticals negotiator to join Newmarket Strategy
Robert Kettell is joining health and life sciences consultancy, Newmarket Strategy. Currently the NHS’s director of Medicines Negotiation, he will join Newmarket as a partner in January. Kettell is one of […]
Robert Kettell is joining health and life sciences consultancy, Newmarket Strategy. Currently the NHS’s director of Medicines Negotiation, he will join Newmarket as a partner in January. Kettell is one of […]
UK: NHS pharmaceuticals negotiator to join Newmarket Strategy
December 3, 2025
Life Sciences
News
People
Pharma
Baird Capital
Singapore: UltraGreen.ai raises US$400m from Singapore IPO
UltraGreen, the global leader in fluorescence-guided surgery, has raised US$400m from its IPO in Singapore, with the public offering said to have received strong interest from institutional and retail investors […]
UltraGreen, the global leader in fluorescence-guided surgery, has raised US$400m from its IPO in Singapore, with the public offering said to have received strong interest from institutional and retail investors […]
Singapore: UltraGreen.ai raises US$400m from Singapore IPO
December 3, 2025
Life Sciences
Medtech – Hospital Equipment
News
Public Equity
65 Equity Partners
UK: Pall Mall Medical acquires Birmingham hospital Kat & Co
Pall Mall Medical, a family-owned independent healthcare group and one of the UK’s fastest-growing providers in the North-West, has acquired Kat & Co, a medical surgery and clinic in Birmingham […]
Pall Mall Medical, a family-owned independent healthcare group and one of the UK’s fastest-growing providers in the North-West, has acquired Kat & Co, a medical surgery and clinic in Birmingham […]
UK: Pall Mall Medical acquires Birmingham hospital Kat & Co
December 3, 2025
Clinical Labs
Healthcare
Hospitals and Clinics
M&A
M&A Deals
Technology: the backbone of healthcare’s organic growth
Healthcare services are evolving at pace, and technology—and AI—is at the heart of that transformation. From occupational health to post-acute care and wellness, tech is no longer an add-on; it […]
Healthcare services are evolving at pace, and technology—and AI—is at the heart of that transformation. From occupational health to post-acute care and wellness, tech is no longer an add-on; it […]
Technology: the backbone of healthcare’s organic growth
December 2, 2025
Analysis
Healthcare
News
Houlihan Lokey
Paul Tomasic
France: Charterhouse Capital Partners invests in Winback to accelerate international expansion plans
Charterhouse Capital Partners, one of the longest established private equity firms operating in Europe, has agreed to invest in Winback, a France-based medtech company specialising in non-invasive medical, rehabilitation, sports […]
Charterhouse Capital Partners, one of the longest established private equity firms operating in Europe, has agreed to invest in Winback, a France-based medtech company specialising in non-invasive medical, rehabilitation, sports […]
France: Charterhouse Capital Partners invests in Winback to accelerate international expansion plans
December 2, 2025
Buy Out
Cosmetic & Aesthetics
Healthcare
M&A
News
Sweden: Anna Ryrberg joins Impilo as investment director
Anna Ryrberg has joined Impilo, an investment company focussed on investments in Nordic healthcare companies, as an investment director. She joins from Summa Equity, where she spent almost nine years, […]
Anna Ryrberg has joined Impilo, an investment company focussed on investments in Nordic healthcare companies, as an investment director. She joins from Summa Equity, where she spent almost nine years, […]
Sweden: Anna Ryrberg joins Impilo as investment director
December 2, 2025
Healthcare
Life Sciences
News
People
Pharma
Italy: EIB and Angelini Ventures to invest €150m in European Life Sciences startups
In what is a first for the European Investment Bank (EIB), it has signed an agreement with a corporate venture capital group in the healthcare sector. The EIB and Angelini […]
In what is a first for the European Investment Bank (EIB), it has signed an agreement with a corporate venture capital group in the healthcare sector. The EIB and Angelini […]
Italy: EIB and Angelini Ventures to invest €150m in European Life Sciences startups
December 2, 2025
Digital Health/Healthtech
Healthcare
Life Sciences
News
Pharma
Denmark: Axcel targets lower mid-market with €459m Elevate Fund I
Axcel has announced the final close of its new lower mid-market fund, Axcel Elevate I, at its hard cap of €459m (US$534m). The fund was oversubscribed. Founded in the Nordics, […]
Axcel has announced the final close of its new lower mid-market fund, Axcel Elevate I, at its hard cap of €459m (US$534m). The fund was oversubscribed. Founded in the Nordics, […]
Denmark: Axcel targets lower mid-market with €459m Elevate Fund I
December 1, 2025
Healthcare
Life Sciences
News
People
Venture
Finland: Jurriaan Dekkers appointed as CFO at Faron Pharamacueticals
Listed Faron Pharmaceuticals, a Finland-based clinical-stage biopharmaceutical company, has appointed Jurriaan Dekkers as CFO. Dekkers brings more than 20 years of experience in biopharma and healthcare companies. Most recently, he […]
Listed Faron Pharmaceuticals, a Finland-based clinical-stage biopharmaceutical company, has appointed Jurriaan Dekkers as CFO. Dekkers brings more than 20 years of experience in biopharma and healthcare companies. Most recently, he […]
Finland: Jurriaan Dekkers appointed as CFO at Faron Pharamacueticals
December 1, 2025
News
People
Pharma
Faron Pharmaceuticals
Finland
Denmark: Rasmus Kofoed appointed as Hedia CEO
Hedia, a medical device developer for people with insulin-requiring diabetes, has appointed Rasmus Kofoed as CEO. His strategic and commercial expertise will guide the company into its next phase of […]
Hedia, a medical device developer for people with insulin-requiring diabetes, has appointed Rasmus Kofoed as CEO. His strategic and commercial expertise will guide the company into its next phase of […]
Denmark: Rasmus Kofoed appointed as Hedia CEO
December 1, 2025
Digital Health/Healthtech
Healthcare
Life Sciences
Medtech – Medical Devices and Implants
News
France: Metric Capital Partners and UI Investissement invest in Excellence Imagerie alongside group’s radiologist partners
Excellence Imagerie is entering a new phase of growth through a reorganisation of its shareholding structure that strengthens its radiologist-led model and reinforces its medical governance. The transaction will position […]
Excellence Imagerie is entering a new phase of growth through a reorganisation of its shareholding structure that strengthens its radiologist-led model and reinforces its medical governance. The transaction will position […]
France: Metric Capital Partners and UI Investissement invest in Excellence Imagerie alongside group’s radiologist partners
December 1, 2025
Buy Out
Diagnostics
Healthcare
Hospitals and Clinics
Life Sciences
UK: Target Healthcare REIT announces acquisition of three operational care homes and the forward commitment of a fourth for £45m
Target Healthcare, a UK listed specialist investor in purpose-built care homes, has completed the acquisition of a portfolio of three performing modern operational care homes, and contracted on a forward […]
Target Healthcare, a UK listed specialist investor in purpose-built care homes, has completed the acquisition of a portfolio of three performing modern operational care homes, and contracted on a forward […]
UK: Target Healthcare REIT announces acquisition of three operational care homes and the forward commitment of a fourth for £45m
December 1, 2025
Care Homes
M&A
M&A Deals
News
Real Assets
Germany: Maxburg Capital partners with founders in shaping AAC’s journey
Maxburg Capital, an investment management company focusing on Germany and the German-speaking markets, has announced its investment in AAC Praxisberatung, a software-based service provider for controlling and auditing of billing […]
Maxburg Capital, an investment management company focusing on Germany and the German-speaking markets, has announced its investment in AAC Praxisberatung, a software-based service provider for controlling and auditing of billing […]
Germany: Maxburg Capital partners with founders in shaping AAC’s journey
November 28, 2025
Life Sciences
Medtech – Healthcare IT
News
Venture
AAC Praxisberatung
Belgium: Gimv joins forces with CNP to accelerate the global expansion of Equine Care Group
European listed private equity investor Gimv is taking an indirect minority stake in Equine Care Group (ECG) from Belgian family-owned investor Compagnie Nationale à Portefeuille (CNP). ECG becomes one of […]
European listed private equity investor Gimv is taking an indirect minority stake in Equine Care Group (ECG) from Belgian family-owned investor Compagnie Nationale à Portefeuille (CNP). ECG becomes one of […]
Belgium: Gimv joins forces with CNP to accelerate the global expansion of Equine Care Group
November 27, 2025
News
Venture
Veterinary
Veterinary Clinics
Bart Diels
Singapore: AGP closes Healthcare Fund at US$150m
August Global Partners (AGP), a Singapore-based independent healthcare and technology investor, has closed its second fund, the AGP Healthcare Fund (AGPHC) at US$150m, surpassing initial fundraising targets and securing commitments […]
August Global Partners (AGP), a Singapore-based independent healthcare and technology investor, has closed its second fund, the AGP Healthcare Fund (AGPHC) at US$150m, surpassing initial fundraising targets and securing commitments […]
Singapore: AGP closes Healthcare Fund at US$150m
November 25, 2025
Buy Out
Digital Health/Healthtech
Healthcare
Life Sciences
Medtech – Medical Devices and Implants
Finland: Adalyon appoints Ulrik Zeuthen as CEO to drive next phase of growth
Finland-based Adalyon, a tech-bio company using its AI-powered speech biomarker platform to transform clinical drug development, has appointed Ulrik Zeuthen as CEO. Adalyon’s proprietary speech-based digital biomarkers provide actionable insights […]
Finland-based Adalyon, a tech-bio company using its AI-powered speech biomarker platform to transform clinical drug development, has appointed Ulrik Zeuthen as CEO. Adalyon’s proprietary speech-based digital biomarkers provide actionable insights […]
Finland: Adalyon appoints Ulrik Zeuthen as CEO to drive next phase of growth
November 25, 2025
Life Sciences
Medtech – Healthcare IT
News
People
Adalyon
UK: Kester announces first and final close of Fund IV at hard cap of £425m
UK-based sector-focused private equity firm, Kester, has announce the first and final close of its fourth fund, Kester Capital Fund IV, at its hard cap of £425m (US$558m). The four-month […]
UK-based sector-focused private equity firm, Kester, has announce the first and final close of its fourth fund, Kester Capital Fund IV, at its hard cap of £425m (US$558m). The four-month […]
UK: Kester announces first and final close of Fund IV at hard cap of £425m
November 25, 2025
Life Sciences
News
Pharma
Venture
Adam Maidment
Switzerland: Microsize and Schedio Group to acquire Lonza’s Micro-Macinazione site in Switzerland
Schedio Group, a Swiss-based engineering group specialising in jet mills, isolators, spray dryers, and particle processing technologies, is making a strategic investment alongside Microsize, a US-bassed CDMO specialising in particle size reduction and […]
Schedio Group, a Swiss-based engineering group specialising in jet mills, isolators, spray dryers, and particle processing technologies, is making a strategic investment alongside Microsize, a US-bassed CDMO specialising in particle size reduction and […]
Switzerland: Microsize and Schedio Group to acquire Lonza’s Micro-Macinazione site in Switzerland
November 25, 2025
M&A
M&A Deals
News
Pharma
Real Assets
France: Eurazeo invests in Excelya to support CRO’s external growth ambitions
France-based mid-market and growth investor Eurazeo is joining Excelya, a European CRO, as a lead investor alongside its management team to support the group in continuing its development and pursuit […]
France-based mid-market and growth investor Eurazeo is joining Excelya, a European CRO, as a lead investor alongside its management team to support the group in continuing its development and pursuit […]
France: Eurazeo invests in Excelya to support CRO’s external growth ambitions
November 24, 2025
Debt
News
Pharma
Services – CRO/CMO/CDMO
Venture
India: Jothi Neeraja initiates exit process for BlackRock’s investment in People Tree Hospitals
Dr Jothi Neeraja, founder, managing director and CEO of People Tree Hospitals – an India-based multispecialty healthcare institution – is facilitating an exit for BlackRock, which invested INR2.1bn (US$24m) in […]
Dr Jothi Neeraja, founder, managing director and CEO of People Tree Hospitals – an India-based multispecialty healthcare institution – is facilitating an exit for BlackRock, which invested INR2.1bn (US$24m) in […]
India: Jothi Neeraja initiates exit process for BlackRock’s investment in People Tree Hospitals
November 24, 2025
Healthcare
Hospitals and Clinics
M&A
News
BlackRock
Switzerland: Peter Hackel to take up CFO role at Medartis in New Year
Publicly-listed Medartis Holding, a Switzerland-based orthopaedic company specialising in head and extremity surgery, has appointed Dr Peter Hackel as its new CFO effective 1 January 2026. He replaces current CFO, […]
Publicly-listed Medartis Holding, a Switzerland-based orthopaedic company specialising in head and extremity surgery, has appointed Dr Peter Hackel as its new CFO effective 1 January 2026. He replaces current CFO, […]
Switzerland: Peter Hackel to take up CFO role at Medartis in New Year
November 24, 2025
News
People
Dirk Kirsten
Matthias Schupp
Medartis
UK: Downing exits six specialist elderly care homes
UK-based investment manager Downing has exited a portfolio of six elderly specialist care homes managed by long-term joint-venture partner UK-based independent care company, Care Concern Group (CCG). This follows an […]
UK-based investment manager Downing has exited a portfolio of six elderly specialist care homes managed by long-term joint-venture partner UK-based independent care company, Care Concern Group (CCG). This follows an […]
UK: Downing exits six specialist elderly care homes
November 24, 2025
Care Homes
Complex Behavioural Care
M&A
M&A Deals
News
The latest insights from
Compass Carter Osborne
Digital transformation or change fatigue? Navigating tech in health and care
Digital transformation or change fatigue? Navigating tech in health and care
November 24, 2025
Healthcare
Insight
Culture in flux: rebuilding trust in a multi-generational workforce
Culture in flux: rebuilding trust in a multi-generational workforce
October 24, 2025
Healthcare
Insight
